Tag: Rahul Koul
“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans
“Our focus is on identifying biological mechanisms that may offer alternative...
Venkat Nelabhotla, Co-Founder, President, and CEO of Vyome Holdings, Inc. shared his insights on the company's long-term vision, its current focus areas, R&D efforts and future outlook
“Research must be designed for translation, not just for publications”: Dr...
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
“Digital technologies are creating a future where care is faster, safer,...
Dr Nikhil Mathur, Group Chief of Medical Services, CARE Group of Hospitals shares insights on the India’s healthcare system, his hospital group’s latest initiatives, tech adoption and more
“Our next big focus is the convergence of AI diagnostics, portable...
Koji Wada, Managing Director, FUJIFILM India shared insights into the company’s key growth drivers, technology trends, business growth and future outlook
BioVoice eMagazine September 2025 | Issue 8 | Volume 6
The Cover Story focuses on the impact of massive tariffs levied by US admin under President, Donald Trump. This edition also features interview of Koji Wada, Managing Director, FUJIFILM India, along with the expert insights by Dr Ashish Gautam of Max Hospital and Vamsi Ravali Pattisapu of Tata Elxsi
Safeguarding Our Healers – India’s Doctors Need Protection
India must stand by its healers. For in protecting them, we are protecting the health and soul of our nation
Face to Face with BioVoice News: Dr Sajeev Nair, Founder &...
Dr. Sajeev Nair, Founder & Chairman of Vieroots speaks about the company’s science-driven, personalized approach to preventive healthcare through genomics, epigenetics, and AI.
“As India’s biofuel market diversifies, digital platforms are emerging as key...
Kishan Karunakaran, CEO, Buyofuel sheds light on the relevance of digital platforms for India’s clean energy targets, biofuel market in India, regulatory challenges, and policy framework
BioVoice eMagazine July-August 2025 | Issue 7 | Volume 6
The Cover Story explores renewed fears around COVID-19 vaccination. This edition also features expert insights from Enbasekar D, Co-Founder & CTO of MediBuddy, along with interviews of Nandakumar Kalathil (Agilent Technologies India), Malti Sachdev (Siemens Healthineers), and Sarvesh Mutha (IntegriMedical)